BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vernalis PLC (Formerly Known As British Biotech PLC) 

Watlington Road

Oxford    OX4 5LY  United Kingdom
Phone: 01865-748747 Fax: 01865-781047


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in anxiety and depression.





 Company News
Vernalis PLC (VNLPY.PK) Change Of Year-End And Commercial Business Update 11/20/2014 2:36:06 PM
Vernalis PLC (VNLPY.PK) Announces CTI BioPharma Becomes Worldwide Licensee For Tosedostat 10/27/2014 11:04:44 AM
Vernalis PLC (VNLPY.PK) Opens US Office And Strengthens US Team With the Appointment Of SVP Medical Affairs 10/10/2014 11:55:42 AM
Vernalis PLC (VNLPY.PK) Release: FDA Accepts Tuzistra™ XR (CCP-01) NDA For Full Review 9/15/2014 8:30:40 AM
Vernalis PLC (VNLPY.PK) Release: Interim Results For The Six Months Ended 30 June 2014 8/6/2014 10:23:56 AM
Vernalis PLC (VNLPY.PK) And Servier Achieve Two Research Milestones In Their Oncology Collaborations 8/4/2014 11:24:28 AM
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014 7:45:21 AM
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014 11:03:05 AM
Vernalis PLC (VNLPY.PK) And Tris Pharma, Inc. Release: Submission Of Tuzistra™ XR (CCP-01) NDA To FDA 6/30/2014 9:15:29 AM
Vernalis PLC (VNLPY.PK) And Servier Achieve Research Milestone As BCL-2 Inhibitor Drug Candidate Enters Phase I 6/19/2014 9:01:10 AM
12345678910...